Stimulation of Caveolin-1 Signaling Improves Arteriovenous Fistula Patency

Objective— Arteriovenous fistulae (AVF) are the most common access created for hemodialysis; however, many AVF fail to mature and require repeated intervention, suggesting a need to improve AVF maturation. Eph-B4 (ephrin type-B receptor 4) is the embryonic venous determinant that is functional in adult veins and can regulate AVF maturation. Cav-1 (caveolin-1) is the major scaffolding protein of caveolae—a distinct microdomain that serves as a mechanosensor at the endothelial cell membrane. We hypothesized that Cav-1 function is critical for Eph-B4–mediated AVF maturation. Approach and Results— In a mouse aortocaval fistula model, both Cav-1 mRNA and protein were increased in the AVF compared with control veins. Cav-1 KO (knockout) mice showed increased fistula wall thickening (P =0.0005) and outward remodeling (P <0.0001), with increased eNOS (endothelial NO synthase) activity compared with WT (wild type) mice. Ephrin-B2/Fc inhibited AVF outward remodeling in WT mice but not in Cav-1 KO mice and was maintained in Cav-1 RC (Cav-1 endothelial reconstituted) mice (WT,P =0.0001; Cav-1 KO,P =0.7552; Cav-1 RC,P =0.0002). Cavtratin—a Cav-1 scaffolding domain peptide—decreased AVF wall thickness in WT mice and in Eph-B4 het mice compared with vehicle alone (WT,P =0.0235; Eph-B4 het,P =0.0431); cavtratin also increased AVF patency (day 42) in WT mice (P =0.0275).Conclusions— Endothelial Cav-1 mediates Eph-B4–mediated AVF maturation. The Eph-B4-Cav-1 axis regulates adaptive remodeling during venous adaptation to the fistula environment. Manipulation of Cav-1 function may be a translational strategy to enhance AVF patency.